The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
第一作者:
Keiko,Okuda
第一单位:
Department of Health Sciences and Preventive Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. keiko_o@koto.kpu-m.ac.jp
作者:
医学主题词
动物(Animals);抗菌药(Anti-Bacterial Agents);细胞系(Cell Line);细胞运动(Cell Movement);细胞存活(Cell Survival);DNA, 互补(DNA, Complementary);多西环素(Doxycycline);基因表达(Gene Expression);胰岛素样生长因子Ⅰ(Insulin-Like Growth Factor I);白细胞介素3(Interleukin-3);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);磷酰化(Phosphorylation);沉淀素试验(Precipitin Tests);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);重组融合蛋白质类(Recombinant Fusion Proteins);底物特异性(Substrate Specificity);酪氨酸(Tyrosine)
DOI
10.1532/ijh97.03125
PMID
15005341
发布时间
2019-10-26
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



